BB

Benjamin Boerger

Vice President Finance at HMNC Brain Health

Benjamin Boerger has a diverse work experience spanning various industries and positions. Benjamin is currently working as the Vice President of Finance at HMNC Brain Health since June 2022. Prior to that, Benjamin was the Director of Finance at Hiscox Germany from February 2018 to May 2022. Benjamin also held the role of Controls & Compliance Germany at Microsoft from April 2017 to February 2018. Benjamin worked as a Senior Accountant at Hiscox Europe Underwriting Ltd. from December 2014 to March 2017. Benjamin also worked at LKC as a Steuerberater and Wirtschaftsprüfer from October 2009 to June 2014 and as a Werkstudent from December 2005 to October 2009. Benjamin worked as a Freelancer at PwC from October 2013 to January 2014. Benjamin also worked as a Gärtner at Wolfgang Zahren Gartengestaltung from June 2006 to October 2009. Benjamin started their career as a Jugendtrainer at TuS Obermenzing e.V. in October 1996 and held the position until October 2009.

Benjamin Boerger obtained their primary education at Ludwig-Maximilians-Universität München from 2004 to 2010, where they pursued a degree in Diplom Kaufmann with a focus on Rechnungswesen und Business/Management. In 2007, they briefly attended Griffith University, specializing in the same field. After completing their studies, Benjamin obtained a Diplom Kaufmann certification from Ludwig-Maximilians-Universität (LMU) München in March 2010. Furthermore, they obtained a Steuerberater certification from the Steuerberaterkammer München in October 2015.

Location

Munich, Germany

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


HMNC Brain Health

HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.


Employees

11-50

Links